Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...

The Dallas-based specialty care platform, valued at $1 billion in 2023 and now rebranded as Lantern, has expanded its ...

FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.

The ASC industry is facing two new, opposing forces: consolidation by large ASC chains and independent ASCs with non-traditional business models.

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

Oak Street Health – a key pillar of CVS Health’s (NYSE: CVS) health care services strategy – has reached a $60 million settlement with the Department of ...

The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.

The Anti-Kickback Statute prohibits anyone from offering or paying, directly or indirectly, money or anything else of value ...